Yuan Cheng

Dr. Yuan Cheng is the 2024 Chair of the East Chapter of the Chinese American Chemical Society and has served as a board member since 2015. He earned his Ph.D. in Biochemistry and Biophysics from the University of North Carolina at Chapel Hill in 2011 and completed his postdoctoral training in the lab of Nobel Laureates Dr. Mike Brown and Dr. Joe Goldstein at the University of Texas Southwestern Medical Center.

With over a decade of experience in the pharmaceutical industry, Dr. Cheng has held key positions at companies such as Bristol Myers Squibb and Regeneron. Currently serving as an Associate Director, he leads a team focused on formulation and process development for antibody and gene therapy.

Dr. Cheng has authored more than 25 publications in peer-reviewed journals and is an active member of the American Association of Pharmaceutical Scientists (AAPS) and the American Society of Gene and Cell Therapy (ASGCT). In 2023, he served as the President of AAPS Protein Purification, Storage, Transportation and Drug-Device Combination Community.